| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| p-value | HR (CI) | p-value | HR (CI) | |
| Therapy (3 groups) | 0.004 | 0.019 | ||
| ADA/MTX | 0.022 | 7.28 (1.32–40.04) | 0.019 | 10.06 (1.67–60.67) |
| ETA/MTX | 0.001 | 5.96 (2.03–17.48) | 0.013 | 4.88 (1.39–17.08) |
| No. non-biological pre-medications >1 | 0.006 | 3.06 (1.39–6.75) | ||
| Pretreatment with steroids | 0.007 | 3.02 (1.34–6.77) | ||
| Steroids baseline | 0.026 | 0.418 (0.19–0.90) | ||
| MTX concomitant | 0.001 | 5.54 (2.08–14.71) | ||
| JADAS baseline | 0.004 | 1.09 (1.03–1.16) | ||
| Mean JADAS-level during observation time | <0.001 | 1.12 (1.05–1.19) | <0.001 | 1.12 (1.05–1.19) |